Intratumoral and Peritumoral Habitat Radiomics of MRI Predict Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy in Oral Squamous Cell Carcinoma

CompletedOBSERVATIONAL

Enrollment

225

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions

Pathologic Complete Response

Trial Locations (1)

Hubei Cancer Hospitla, Wuhan

All Listed Sponsors

collaborator

Hubei Cancer Hospital

OTHER

lead

Zilong Yuan

OTHER